Damien Bertheloot
0000-0002-9495-706X
Publication & Citation Trends
Most Cited Works
Publications
27 total
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor
Cited by 23
OpenAlex
Novel Method for the Rapid Establishment of Antibiotic Susceptibility Profiles in Bacterial Strains Linked to Musculoskeletal Infections Using Scattered Light Integrated Collector Technology PDF
Cited by 4
OpenAlex
Calcium-independent phospholipase A2 is a novel regulator of NLRP3 inflammasome activation and pro-inflammatory cytokine release 3889
Cited by 0
Semantic Scholar
Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes PDF
Cited by 16
OpenAlex
Measuring NLR Oligomerization II: Detection of ASC Speck Formation by Confocal Microscopy and Immunofluorescence.
Cited by 10
Semantic Scholar
Platelet-derived transcription factors license human monocyte inflammation OA
Cited by 2
Semantic Scholar
Nanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation <i>in vivo</i> PDF
Cited by 43
OpenAlex
Research Topics
Inflammasome and immune disorders
(9)
Immune Response and Inflammation
(8)
Advanced Glycation End Products research
(8)
interferon and immune responses
(4)
Immunotherapy and Immune Responses
(2)
Frequent Co-Authors
Affiliations
University of Bonn
University Hospital Bonn
Ifm Therapeutics (United States)
Institut für Mittelstandsforschung